Program
eltrombopag
Also written as “Eltrombopag”, “SB497115” and “Eltrombopag olamine”.
Its studies are mostly in Purpura, Thrombocytopenic, Idiopathic · Thrombocytopenia · Anemia, Aplastic · Purpura · Hepatitis C, Chronic, led by 4 companies.
Drug pageEltrombopag: every studyAll 135 studies of it, academic ones too, with its approvals, label and forms.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| GlaxoSmithKline | 290 open or running | phase 4since Jan 7, 2010 | Feb 1, 2005 | none ahead |
| Novartisits history only | 182 open or running | phase 4since Oct 4, 2013 | Jul 10, 2006 | Apr 22, 2033phase 2 · NCT07660172 |
| Bristol-Myers Squibbits history only | 10 open or running | phase 1since Jun 20, 2023 | Jun 20, 2023 | none ahead |
| Renataits history only | 11 open or running | phase 2since Jul 6, 2024 | Jul 6, 2024 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of GlaxoSmithKline only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
Before these, 15 studies since Feb 1, 2005.
- Jan 29, 2009Phase 1 study in Hepatitis CNCT00833378 · 40 enrolled · United States
- Mar 5, 2009Phase 2 study in Liver DiseasesNCT00861601 · 38 enrolled · Japan
- May 14, 2009Phase 1 study in Myelodysplastic SyndromesNCT00903422 · 98 enrolled · United States, Brazil, Denmark and more
- May 21, 2009Phase 2 study in PurpuraNCT00908037 · 82 enrolled · United States, Canada, France and more
- Oct 1, 2009Phase 3 study in Hepatitis CNCT00996216 · 27 enrolled · United States, Australia, Canada and more
- Jan 7, 2010Phase 4 study in ThrombocytopeniaNCT01055600 · United States
- Feb 12, 2010Phase 1 study in PurpuraNCT01072162 · 40 enrolled · United States
- Mar 25, 2010Phase 4 study in PurpuraNCT01098487 · 167 enrolled · United States, Czech Republic, France and more
- May 20, 2010Phase 2 study in ThrombocytopeniaNCT01147809 · 130 enrolled · United States, Belgium, Canada and more
- Dec 21, 2011Phase 3 study in Purpura, Thrombocytopenic, IdiopathicNCT01520909 · 92 enrolled · United States, Argentina, Czech Republic and more
- Jul 5, 2012Phase 2 study in Hepatitis C, ChronicNCT01636778 · 45 enrolled · Japan
- Aug 2, 2012Phase 1 study in ThrombocytopeniaNCT01657552 · 56 enrolled · United States
- Sep 29, 2014Phase 1 study in Liver CirrhosisNCT02254434 · 26 enrolled · Mexico
- Oct 30, 2014Phase 1 study in Purpura, Thrombocytopenic, IdiopathicNCT02281370 · 39 enrolled · United States
TargetBeta
“Thrombopoietin receptor agonist; Thrombopoietin receptor agonist”ChEMBL 37, by rule
Other programs on MPL
| Program | Company | Furthest phase | Studies |
|---|---|---|---|
| romiplostimrule | Amgen | phase 4 | 38 |
| avatrombopagrule | Eisai | phase 4 | 25 |
| hetrombopag olaminerule | Jiangsu HengRui Medicine | phase 3 | 15 |
Studies
All 29 GlaxoSmithKline leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT02281370Purpura, Thrombocytopenic, Idiopathic · United States | 1 | Completed | Dec 24, 2014 | 39 |
| NCT02254434Liver Cirrhosis · Mexico | 1 | Completed | Sep 8, 2014 | 26 |
| NCT01657552Thrombocytopenia · United States | 1 | Completed | Oct 26, 2012 | 56 |
| NCT01636778Hepatitis C, Chronic · Japan | 2 | Completed | May 2014 | 45 |
| NCT01520909Purpura, Thrombocytopenic, Idiopathic · United States, Argentina, Czech Republic and more | 3 | Completed | Jan 2014 | 92 |
| NCT01147809Thrombocytopenia · United States, Belgium, Canada and more | 2 | Completed | Jan 2015 | 130 |
| NCT01098487Purpura · United States, Czech Republic, France and more | 4 | Completed | May 2014 | 167 |
| NCT01072162Purpura · United States | 1 | Completed | Apr 7, 2010 | 40 |
| NCT01055600Thrombocytopenia · United States | 4 | Withdrawn | Jul 2014 | 0 |
| NCT00996216Hepatitis C · United States, Australia, Canada and more | 3 | Completed | Feb 2013 | 27 |
| NCT00908037Purpura · United States, Canada, France and more | 2 | Completed | Feb 1, 2014 | 82 |
| NCT00903422Myelodysplastic Syndromes · United States, Brazil, Denmark and more | 1 | Completed | Jun 26, 2012 | 98 |
| NCT00861601Liver Diseases · Japan | 2 | Completed | Aug 2009 | 38 |
| NCT00833378Hepatitis C · United States | 1 | Completed | Mar 11, 2009 | 40 |
| NCT00828750Purpura, Thrombocytopenic, Idiopathic · Japan | 3 | Completed | Feb 2011 | 19 |
| NCT00688272Purpura · United Kingdom | 1 | Completed | Sep 25, 2008 | 36 |
| NCT00678587Non-alcoholic Fatty Liver Disease · United States, Argentina, Belgium and more | 3 | Terminated | Oct 2009 | 292 |
| NCT00540423Purpura, Thrombocytopenic, Idiopathic · Japan | 3 | Completed | Dec 2008 | 23 |
| NCT00529568Hepatitis C, Chronic · United States, Australia, Belgium and more | 3 | Completed | Aug 2011 | 759 |
| NCT00516321Hepatitis C, Chronic · United States, Australia, Belgium and more | 3 | Completed | Apr 2011 | 687 |
| NCT00487968Purpura, Thrombocytopenic, Idiopathic · United States | 1 | Completed | 12 | |
| NCT00442871Purpura · United States | 1 | Completed | Jan 3, 2008 | 29 |
| NCT00424177Purpura · Germany, Russian Federation | 2 | Completed | Aug 2008 | 66 |
| NCT00370331Purpura · United States, Austria, Canada and more | 3 | Completed | Jul 2008 | 197 |
| NCT00359463Purpura · United States, Australia, New Zealand | 1 | Completed | Mar 7, 2007 | 33 |
| NCT00358540Thrombocytopenia · United States | 1 | Completed | Oct 22, 2010 | 18 |
| NCT00110799Hepatitis C, Chronic · United States, France, Germany and more | 2 | Completed | Oct 2006 | 75 |
| NCT00102739Purpura · Germany, Greece, Hong Kong and more | 2 | Completed | Jan 2007 | 99 |
| NCT00102726Thrombocytopenia · United States, Argentina, Austria and more | 2 | Completed | Feb 2007 | 183 |
How it is read
Names in the registry
- “Eltrombopag”, 19 entries
- “eltrombopag”, 15 entries
- “SB497115”, 3 entries
- “Eltrombopag olamine”, 2 entries
- “Eltrombopag 25 MG”, 1 entry
Conditions, from the studies’ own filings
- Purpura, Thrombocytopenic, Idiopathic, 15 studies
- Thrombocytopenia, 8 studies
- Anemia, Aplastic, 6 studies
- Purpura, 5 studies
- Hepatitis C, Chronic, 4 studies
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.